Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Neutropenia and FCGR2A[original query] |
---|
FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts. Hematological oncology 2016 Jun . Ghesquières Hervé, Larrabee Beth R, Haioun Corinne, Link Brian K, Verney Aurélie, Slager Susan L, Ketterer Nicolas, Ansell Stephen M, Delarue Richard, Maurer Matthew J, Fitoussi Olivier, Habermann Thomas M, Peyrade Fréderic, Dogan Ahmet, Molina Thierry J, Novak Anne J, Tilly Hervé, Cerhan James R, Salles Gill |
A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance). Annals of oncology : official journal of the European Society for Medical Oncology 2017 9 28 (11): 2806-2812. Martin P, Jung S-H, Pitcher B, Bartlett N L, Blum K A, Shea T, Hsi E D, Ruan J, Smith S E, Leonard J P, Cheson B |
Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab. Arthritis research & therapy 2017 Mar 19 (1): 44. Ajeganova Sofia, Tesfa Daniel, Hägglund Hans, Fadeel Bengt, Vedin Inger, Zignego Anna Linda, Palmblad J |
Genetic variations in low-to-medium-affinity Fc? receptors and autoimmune neutropenia in early childhood in a Danish cohort. International journal of immunogenetics 2023 2 50 (2): 65-74. Kløve-Mogensen Kirstine, Steffensen Rudi, Masmas Tania Nicole, Glenthøj Andreas, Jensen Christina Friis, Haunstrup Thure Mors, Ratcliffe Paul, Höglund Petter, Hasle Henrik, Nielsen Kaspar Re |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: